A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is extracorporeal membrane oxygenation (ECMO) superior to dedicated ventricular assist device (VAD) in patients with acutely failing allograft following transplantation. Altogether, 162 papers were found using the reported search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two studies provide data only for ECMO-treated patients, in three, the authors describe their experiences with Levitronix CentriMag and three studies directly compare the outcomes of ECMO and VAD support. The survival ranges from 40 to 74% in patients rescued with ECMO compared with 33-60% in patients supported with dedicated VAD. We conclude that there is insufficient evidence to prefer ECMO over VAD and the optimal modality of mechanical circulatory support (MCS) following heart transplantation should be determined by the surgeon and institutional experience and dependent on the extent and severity of myocardial dysfunction and the presence or absence of associated respiratory insufficiency.

Department of Cardiac Surgery Institute for Clinical and Experimental Medicine Videnska Prague Czech Republic

See more in PubMed

Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg. 2003;2:405–9. doi:10.1016/S1569-9293(03)00191-9. PubMed DOI

Taghavi S, Zuckermann A, Ankersmit J-H, Wieselthaler G, Rajek A, Laufer G, et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg. 2004;78:1644–9. doi:10.1016/j.athoracsur.2004.04.059. PubMed DOI

Chou N-K, Chi H-H, Ko W-J, Yu H-Y, Huang S-C, Wang S-S, et al. Extracoroporeal membrane oxygenation for perioperative cardiac allograft failure. ASAIO J. 2006;52:100–3. doi:10.1097/01.mat.0000196514.69525.d9. PubMed DOI

Marasco SF, Vale M, Pellegrino V, Preovolos A, Leet A, Kras A, et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann Thorac Surg. 2010;90:1541–6. doi:10.1016/j.athoracsur.2010.05.066. PubMed DOI

D'Alessandro C, Aubert S, Golmard JL, Praschker BL, Luyt CE, Pavie A, et al. Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation. Eur J Cardiothorac Surg. 2010;37:343–9. PubMed

Shuhaiber JH, Jenkins D, Berman M, Parameshwar J, Dhital K, Tsui S, et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant. 2008;27:158–64. doi:10.1016/j.healun.2007.10.015. PubMed DOI

Thomas HL, Dronavalli VB, Parameshwar J, Bonser RS, Banner NR. Steering Group of the UKCTA: incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur J Cardiothorac Surg. 2011;40:1348–54. PubMed

Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009;28:971–6. doi:10.1016/j.healun.2009.04.015. PubMed DOI

Mihaljevic T, Jarrett CM, GV G-S, Smedira NG, Nowicki ER, Thuita L, et al. Mechanical circulatory support after heart transplantation. Eur J Cardiothorac Surg. 2012;41:200–6. PubMed PMC